2 months after the original post and working across the local/global market, the statement "It isn't the Tech that makes ADO Uninvestible" continues to dominate.
The CEO's last update was to a 9th Grade High School level at best and embarrassingly naïve when compared to the technical criteria for a complex multi Billion$ cell development. At worst it's disrespectful to any key player in the industry when considering advanced electrolytes, novel binders, pre-lithiation regimes, separators, size, application and comparisons to high (90%) silicon oxide content using graphene nanotubes.
It's no personal indictment just a fact that all serious players/investors in the space will confirm.
It also appears to be a step backward in capability over the past 2 years while the industry is forging ahead.
Attached, as a wake up call, is the 150 Entities with 1000's of Si Anode related patents just in the past 2 years. If we add China the list of entities is 700+.
These are Newcomers in the past 2 years only.
They are all represented by some of the most respected and best technical minds in the Electrode Chemistry and Manufacturing spaceThe leadership of each have a commanding knowledge/experience in the Si Anode Technology Development Architecture. We have always believed AnteoTech's technology could be on the list but not with the current business model.
Need to stop the "no questions allowed" 9th Grade Science presentations.
Get the 2 seasoned players to the front of house.
The CTO and Germany based CTO from the Nov podcast are the only credible front people.
It's still too risky for institutional investors unless the flawed leadership and business model are addressed. A clarion call for independent directors and major shareholders.
IN terms of risk, there could be a future minority shareholder class action if the company shuts and returns capital to shareholders given the Selective Disclosures to a select group of shareholders - ASIC is paying close attention to this and enforcing Regulatory Guide 62 and policies for making briefing presentations, speaking notes and speeches available to the public in a timely fashion. The market has to operate fairly and not for a top 20
Lets hope Ultranode gets its day in a full production cell
Independent Directors need to engage the Chair and CEO as the business is moving from life support to terminal
(20min delay)